WCM
RYTM icon

Wedge Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Wedge Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Sell
23,422
-1,113
-5% -$101K 0.04% 288
2026
Q1 		$2.13M Buy
24,535
+5,288
+27% +$514K 0.04% 335
2025
Q4 		$2.06M Sell
19,247
-2,997
-13% -$318K 0.04% 340
2025
Q3 		$2.25M Sell
22,244
-7,747
-26% -$719K 0.04% 331
2025
Q2 		$1.9M Sell
29,991
-6,993
-19% -$428K 0.03% 331
2025
Q1 		$1.96M Sell
36,984
-11,427
-24% -$634K 0.04% 329
2024
Q4 		$2.71M Sell
48,411
-433
-0.9% -$23.9K 0.05% 286
2024
Q3 		$2.56M Sell
48,844
-14,353
-23% -$688K 0.04% 292
2024
Q2 		$2.59M Sell
63,197
-10,676
-14% -$426K 0.05% 283
2024
Q1 		$3.2M Sell
73,873
-2,634
-3% -$115K 0.05% 278
2023
Q4 		$3.52M Sell
76,507
-28,213
-27% -$890K 0.06% 270
2023
Q3 		$2.4M Sell
104,720
-113,705
-52% -$2.55M 0.05% 291
2023
Q2 		$3.6M Buy
+218,425
New +$3.94M 0.06% 312

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Wedge Capital Management's RYTM Position: Q2 2026 in Review

Wedge Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 4.5% in Q2 2026, selling an estimated $101K and leaving 23,422 shares worth $2.6M. The position accounts for 0.04% of the portfolio, ranked #288.

Wedge Capital Management first reported a position in RYTM in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.6M in Q2 2023. 39 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Wedge Capital Management held 23,422 shares of Rhythm Pharmaceuticals worth $2.6M as of Q2 2026.
  • Wedge Capital Management sold 1,113 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Rhythm Pharmaceuticals made up 0.04% of Wedge Capital Management's portfolio in Q2 2026, its #288 holding.
  • Wedge Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Wedge Capital Management's Rhythm Pharmaceuticals position peaked at $3.6M in Q2 2023.
  • 39 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.